FDA grants nivolumab accelerated approval for MSI-H or dMMR colorectal cancer

17th August 2017 Uncategorised 0

European Society for Medical Oncology News

More: FDA grants nivolumab accelerated approval for MSI-H or dMMR colorectal cancer
Source: MDlinx